CFO Glenn Worman resigns; Saleem Elmasri appointed as CFO of Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp.

Glenn Worman resigned as CFO and principal financial & accounting officer on Oct 8, 2025; no disagreement cited.
Saleem Elmasri appointed CFO effective Nov 17, 2025; will serve via Titan Advisory Services LLC.
Elmasri receives $42,000/year ($3,500/month) consulting fee and 100,000 ordinary shares upon engagement.
Elmasri is a CPA with 20 years experience, previously at PwC and as managing partner at Titan Advisory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.